开发一个可扩展的复合系统,用于循环β-1,2-葡萄糖的生产
L Soledad Guidolin1, A Josefina Caillava2, Malena Landoni3
1Instituto de Investigaciones Biotecnológicas, Escuela de Bio y Nanotecnologías (EByN), Universidad Nacional de San Martín (UNSAM)-Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Universidad Nacional de San Martín, San Martín, Buenos Aires, Argentina. sguidolin@iib.unsam.edu.ar.
Microbial cell factories
|May 6, 2024
概括
工程化大肠杆菌有效地产生循环β-1,2-葡萄糖 (CβG),一种多功能多糖. 这种可扩展的方法克服了天然细菌生产的局限性,使CβG在生物技术和工业中得到更广泛的应用.
科学领域:
- 生物技术和合成生物学
- 生物聚合物的微生物生产
- 碳水化合物化学 碳水化合物化学
背景情况:
- 循环β-1,2-葡萄糖 (CβG) 是细菌多糖类,具有高溶解性和分子封装等有价值的特性.
- 目前的生产方法受到缓慢生长或致病原生细菌以及缺乏化学合成途径的限制.
- 可扩展且具有成本效益的CβG生产对于扩大其工业和商业应用至关重要.
研究的目的:
- 使用工程细菌开发一种新的,可扩展的循环β-1,2-葡萄糖 (CβG) 生产系统.
- 克服传统CβG合成和净化方法的局限性.
- 增加CβG的可用性,用于各种生物技术应用.
主要方法:
- 通过删除内在的多糖生物合成基因,创造了工程化大肠杆菌菌株.
- 进行了CβG合成,运输和化酶的异质表达.
- 高细胞密度培养 (HCDC) 用于优化CβG生产.
主要成果:
- 工程化大肠杆菌成功地产生了非替代CβG,阴离子CβG和高尺寸CβG.
- 一个菌株将未被替代的CβG (聚合度1724) 分泌到培养基中.
- 在48小时内,高细胞密度培养实现了4.5g/L的纯非替代CβG的产量.
结论:
- 在大肠杆菌中成功开发了一种用于CβG合成的新复合细菌系统.
- 该系统提供了高产量和CβG生产报告的最高体积生产率.
- 这种方法的可扩展性预计将提高CβG用于研究和工业用途的可用性.
相关概念视频
Biosynthesis of Polysaccharides
Polysaccharides such as glycogen and starch are synthesized from nucleoside diphosphate sugars, primarily uridine diphosphate glucose (UDPG) and adenosine diphosphate glucose (ADPG). These activated glucose donors act as key intermediates in carbohydrate metabolism and biosynthesis. UDPG primarily involves glycogen synthesis in animals and many bacteria, while ADPG plays a fundamental role in starch synthesis in plants and certain bacteria.UDPG is formed when glucose-1-phosphate reacts with...
Bioreactor Controls-III
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
Production of Alcohol
Continuous fermentation is a key strategy in industrial ethanol production, particularly when efficiency, scalability, and high yields are essential. This approach allows for uninterrupted operation and optimized resource utilization. The primary feedstock, corn starch, undergoes enzymatic hydrolysis facilitated by α-amylase and glucoamylase. These enzymes break down the starch into fermentable sugars such as glucose, which are readily assimilated by fermentative microorganisms.Fermentation...
Production of Organic Acids
Lactic acid, an important organic acid extensively applied in food, pharmaceutical, and biodegradable polymer industries, is primarily produced via microbial fermentation. This method is favored over chemical synthesis due to its environmental sustainability and capacity for enantiomerically pure product formation. Among various microbial processes, the fermentation of starch-based substrates stands out due to the abundance and renewability of raw materials like corn and potatoes.Hydrolysis of...
Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...


